Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep;19(3):231-242.
doi: 10.1007/s11154-018-9462-3.

Fertility Preservation Options in Transgender People: A Review

Affiliations
Review

Fertility Preservation Options in Transgender People: A Review

Natnita Mattawanon et al. Rev Endocr Metab Disord. .

Abstract

Gender affirming procedures adversely affect the reproductive potential of transgender people. Thus, fertility preservation options should be discussed with all transpeople before medical and surgical transition. In transwomen, semen cryopreservation is typically straightforward and widely available at fertility centers. The optimal number of vials frozen depends on their reproductive goals and treatment options, therefore a consultation with a fertility specialist is optimal. Experimental techniques including spermatogonium stem cells (SSC) and testicular tissue preservation are technologies currently under development in prepubertal individuals but are not yet clinically available. In transmen, embryo and/or oocyte cryopreservation is currently the best option for fertility preservation. Embryo cryopreservation requires fertilization of the transman's oocytes with a donor or partner's sperm prior to cryopreservation, but this limits his future options for fertilizing the eggs with another partner or donor. Oocyte cryopreservation offers transmen the opportunity to preserve their fertility without committing to a male partner or sperm donor at the time of cryopreservation. Both techniques however require at least a two-week treatment course, egg retrieval under sedation and considerable cost. Ovarian tissue cryopreservation is a promising experimental method that may be performed at the same time as gender affirming surgery but is offered in only a limited amount of centers worldwide. In select places, this method may be considered for prepubertal children, adolescents, and adults when ovarian stimulation is not possible. Novel methods such as in-vitro activation of primordial follicles, in vitro maturation of immature oocytes and artificial gametes are under development and may hold promise for the future.

Keywords: Fertility preservation; Reproduction; Transgender; Transgender health.

Similar articles

See all similar articles

Cited by 10 articles

See all "Cited by" articles

References

    1. Science. 2017 Apr 14;356(6334): - PubMed
    1. J Assist Reprod Genet. 2015 Aug;32(8):1195-6 - PubMed
    1. Nature. 2016 Nov 10;539(7628):299-303 - PubMed
    1. Hum Reprod. 2015 Nov;30(11):2457-60 - PubMed
    1. Obstet Gynecol. 2017 Jun;129(6):1031-1034 - PubMed

LinkOut - more resources

Feedback